EarningsCENTRALPHL
CENTRALPHL Earnings Update
Announcement summary
- What happened
- CENTRALPHL published a corporate disclosure on 2 May 2024. Read the full announcement for details.
- Company
- Central Pharmaceuticals Limited
- Announcement published
Original announcement
(Q3 Un-audited): EPS was Tk. (0.16) for January-March 2024 as against Tk. (0.05) for January-March 2023; EPS was Tk. (0.31) for July 2023-March 2024 as against Tk. (0.19) for July 2022-March 2023. NOCFPS was Tk. (0.00) for July 2023-March 2024 as against Tk. (0.00) for July 2022-March 2023. NAV per share was Tk. 7.10 as on March 31, 2024 and Tk. 5.59 as on June 30, 2023.
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 66330e94edb49c4b75d44703
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from CENTRALPHL
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.